1. Home
  2. HLMN vs VIR Comparison

HLMN vs VIR Comparison

Compare HLMN & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hillman Solutions Corp.

HLMN

Hillman Solutions Corp.

HOLD

Current Price

$7.11

Market Cap

1.4B

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$10.67

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLMN
VIR
Founded
1964
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
HLMN
VIR
Price
$7.11
$10.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$11.60
★ $19.43
AVG Volume (30 Days)
1.6M
★ 1.7M
Earning Date
04-27-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 122.22
17.49
EPS
★ 0.08
N/A
Revenue
★ $1,552,224,000.00
$68,556,000.00
Revenue This Year
$7.65
$270.22
Revenue Next Year
$4.67
N/A
P/E Ratio
$87.94
★ N/A
Revenue Growth
★ 5.41
N/A
52 Week Low
$6.85
$4.82
52 Week High
$10.85
$11.94

Technical Indicators

Market Signals
Indicator
HLMN
VIR
Relative Strength Index (RSI) 37.02 47.56
Support Level $6.98 $10.23
Resistance Level $7.66 $10.67
Average True Range (ATR) 0.21 0.47
MACD 0.02 -0.10
Stochastic Oscillator 25.17 12.42

Price Performance

Historical Comparison
HLMN
VIR

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S, Canada and Mexico.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: